Apr 8, 2020

Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Sophie PerinelXavier Delavenne

Abstract

Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all ongoing clinical trials with HCQ use different dosing regimens, resulting on various concentrations PK studies are therefore needed to define the optimal dosing regimen.

  • References9
  • Citations8

Citations

Mentioned in this Paper

Drug Kinetics
Hydroxychloroquine
Study
Treatment Protocols
Clinical Trials
A 19
Intensive Care Unit

Related Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.